Dr. Farhad Rafii, MD

Dr. Rafii practices at Interventional Cardiology Medical Group, Inc in West Hills, California.

Dr. Rafii's NPI, 1740433705, was assigned on November 3, 2008. Dr. Rafii graduated from Keck School of Medicine of USC in 2007. Dr. Rafii holds California license A105505.

Dr. Rafii's primary practice is Interventional Cardiology Medical Group, Inc, at 7301 N Medical Center Dr, West Hills, CA 91307 in Los Angeles County. The practice phone is (818) 702-8800.

Dr. Rafii's primary practice is Interventional Cardiology Medical Group, Inc in West Hills, California. Dr. Rafii is also affiliated with UCLA West Valley Medical Center. The medical group on file is Interventional Cardiology Medical Group. Dmand AI also links Dr. Rafii to 4 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rafii practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Rafii's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Rafii is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Rafii's licenses on file in 2 states: California and Texas.

Dmand AI lists aneurysm, aortic atherosclerois, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease, chronic hypertension and chronic skin ulcer among the conditions Dr. Rafii treats.

CMS data shows 12,561 Medicare services from Dr. Rafii across 49 procedure codes in 2024, for 1,181 Medicare patients. Medicare paid $927,544 for them.

CMS counts 1,181 Medicare patients who saw Dr. Rafii in 2024. The largest group is 75 to 84, with 476 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 35% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rafii's median patient age at 74, with 47% women.

In 2024, Dr. Rafii wrote 8,909 Medicare Part D claims for 935 patients. 84% of them were for generic drugs. CMS names the drug for 8,526 of them, across 81 drugs with 11 or more claims each, at $1,515,143 in total drug cost. In 2023, CMS named 7,368 claims across 73 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Rafii for performance year 2024, reported as part of a group. Dr. Rafii accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rafii as offering telehealth. CMS counts 44 procedures of varicose vein removal by Dr. Rafii, more than 72% of the clinicians it reports for that procedure.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Rafii, published from 2005 to 2024. Dr. Rafii's most frequent co-authors are James E. Ip, MD, Norman E. Lepor, MD and Fernando Mendoza, MD.

Dmand AI links Dr. Rafii to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Anemia, Iron-Deficiency, Myocardial Infarction and Anemia, Hypochromic. Open Payments lists research payments to Dr. Rafii that name 1 trial.

CMS Open Payments shows 1,576 general payments to Dr. Rafii from 52 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 75% of the total. Novartis Pharmaceuticals Corporation paid the most, $200,649. It also lists 2 research payments totaling $94,271 in 2024, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Rafii.

Dr. Rafii graduated from Keck School of Medicine of USC in 2007. Dr. Rafii is a member of ACC, AHA, AMA, ASE, CMA and HRS.

Dr. Rafii is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.